Akero Therapeutics (AKRO)
(Delayed Data from NSDQ)
$21.00 USD
+0.75 (3.70%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $21.02 +0.02 (0.10%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/20/2024
Time: -- |
3/2024 | $-0.90 | 28.89% |
Earnings Summary
For their last quarter, Akero Therapeutics (AKRO) reported earnings of -$0.99 per share, missing the Zacks Consensus Estimate of -$0.82 per share. This reflects a negative earnings surprise of 20.73%. Look out for AKRO's next earnings release expected on May 20, 2024. For the next earning release, we expect the company to report earnings of -$0.90 per share, reflecting a year-over-year decrease of 63.64%.
Earnings History
Price & Consensus
Zacks News for AKRO
Ionis (IONS) Drug Meets Mid-Stage MASH Study Goals
AKRO: What are Zacks experts saying now?
Zacks Private Portfolio Services